Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

B of A Securities Maintains Buy on Merck & Co, Lowers Price Target to $145

Author: Benzinga Newsdesk | July 31, 2024 01:24pm

B of A Securities analyst Geoff Meacham maintains Merck & Co (NYSE:MRK) with a Buy and lowers the price target from $150 to $145.

Posted In: MRK